Gold Intraday: Steady Up Trend

Investors were caught between the latest development in coronavirus treatment and uncertainty over U.S.-China relationship, however technically gold's bullish trend is still steady...

Gold 1

On Friday, spot gold marked a day-high near $1,811 before closing 0.3% lower at $1,799. Investors were caught between the latest development in coronavirus treatment and uncertainty over U.S.-China relationship.

U.S. biopharmaceutical giant Gilead Sciences released additional data on remdesivir, an investigational antiviral for the treatment of COVID-19, which showed an improvement in clinical recovery and a 62 percent reduction in the risk of mortality compared with standard of care.

Meanwhile, U.S. President Donald Trump said he is not considering a phase two trade deal and "the relationship with China has been severely damaged".

From a technical point of view, spot gold maintains a steady up trend as shown on the 1-hour chart. It is currently trading at the middle of a bullish channel drawn from July 5. The level at $1,786 might be consider as the nearest support, which is located close to the lower boundary of the channel and the 78.6% Fibonacci retracement support of the rally from July 5, while a break above the nearest resistance at $1,818 would open a path to the next resistance at $1,831.

In an alternative scenario, losing $1,786 would suggest that the next support at $1,773 is exposed.

Source: TradingView, Gain Capital

More from Gold

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.